c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells
Leona Gabryšová(The Francis Crick Institute), Anne O’Garra(The Francis Crick Institute), Jan Sodenkamp(The Francis Crick Institute), Luke S. Cox(The Francis Crick Institute), Yashaswini Kannan(The Francis Crick Institute), Marisol Alvarez-Martinez(The Francis Crick Institute), James Briscoe(Health Affairs), Nicholas M. Luscombe(Yale University), Michael H. Sieweke(Centre National de la Recherche Scientifique), Krzysztof Potempa(The Francis Crick Institute), Mark S. Wilson(Gene Therapy Laboratory), Greg Elgar(Genomics England), Caroline Hosking(The Francis Crick Institute), Leena Bhaw(Queen Mary University of London), Xuemei Wu(Chongqing Medical University), Damián Pérez‐Mazliah(The Francis Crick Institute), Jean Langhorne(The Francis Crick Institute), Vicki Metzis(The University of Queensland), Hagen Wende(Max Delbrück Center), Charlotte Whicher(The Francis Crick Institute)
Cited by 157
Related Papers
The regulation of IL-10 production by immune cells
|Nature reviews. Immunology|2010|3.1k
Type I interferons in infectious disease
|Nature reviews. Immunology|2015|2.7k
In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines
|The Journal of Experimental Medicine|2002|1.2k
Biology and therapeutic potential of interleukin-10
|The Journal of Experimental Medicine|2019|1.1k
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k